|
Recommended Changes / Reasons
|
Lines: 1232-1234
Section: 12.80
|
In this section it is stated that analytical methods in the current edition of official pharmacopoeia are considered validated. Does this mean that FDA will consider an analytical method in the current European Pharmacopoeia or Japanese Pharmacopoeia to be validated?
|
|
Recommended Change Type: General Comments
|
To clarify the scope of the the reference to official compendia and validated analytical methods.
|